Tavolimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Tavolimab Usage And Synthesis

Uses

Tavolixizumab (MEDI 0562; Tavolimab) is a human monoclonal antibody to TNFRSF4 (TNF receptor superfamily member 4) for use in cancer immunology research[1].

References

[1] Claudia Giampietri, et al. Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies. J Transl Med. 2022 Oct 12;20(1):467. DOI:10.1186/s12967-022-03670-7

Tavolimab(1635395-25-3)Related Product Information

• Gremubamab
• Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 κ-chain, dimer
• Abrezekimab
• Atorolimumab
• Glenzocimab
• Lorigerlimab
• Denintuzumab
• Ozoralizumab
• Lintuzumab
• Gedivumab